联系我们
联系人：陈先生
产品展示
ALDOA Human/ 重组人醛缩酶A
点击次数：693
价格：￥电议
更新日期：2026/8/24 23:18:11
生 产 地：欧洲
产品型号：
商家名片
陈**
联系我时，请说明是阿仪网看到的，谢谢!
- 电话: 05*******891
- 手机: 18******628
- 微信:
- 交换名片后展示联系方式 → →
相关标签：ALDOA,Human,重组人醛缩酶A
详细内容
慧嘉生物您实验身边的好伙伴
为客户提供“最高品质的产品”和“最优质的服务”
AssayBiotech CUSABIO Immunoway Santa Abcam Cst jackson Pierce Sigma Amresco Qiagen Cayman abnova millipore invitrogen merk ebioscience prospec lifespan BD
欢迎广大客户咨询，另有大量宣传海报和小礼品赠送。
网站：www..com
Q Q：
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
Synonyms Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. Introduction AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. Description ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. Source Escherichia Coli. Physical Appearance Sterile Filtered clear colorless solution. Formulation The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. Stability ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. Amino acid sequence MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. Purity Greater than 95.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
ALDOA Human/ 重组人醛缩酶A
产品编号：ENZ-486
产品规格：5μg/20μg/1mg
产品规格：5μg/20μg/1mg
| Synonyms | Fructose-bisphosphate aldolase A, Muscle-type aldolase, Lung cancer antigen NY-LU-1, ALDOA, ALDA, EC 4.1.2.13, GSD12, MGC10942, MGC17716, MGC17767, Aldolase-A. |
| Introduction | AKR7A2 participates in the detoxification of aldehydes ａnd ketones. AKR7A2 catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. AKR7A2 is involved in producing the neuromodulator gamma-hydroxybutyrate （GHB）. AKR7A2 has extensive substrate specificity. AKR7A2 shows NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde ａnd pyridine-2-aldehyde （in vitro）. AKR7A2 reduces 1,2-naphthoquinone ａnd 9,10-phenanthrenequinone （in vitro）. AKR7A2 reduces the dialdehyde protein-binding form of aflatoxin B1 （AFB1） to the non-binding AFB1 dialcohol. AKR7A2 takes part in protection of liver against the toxic ａnd carcinogenic effects of AFB1, a potent hepatocarcinogen. |
| Description | ALDOA Human Recombinant fused to 20 amino acid His Tag at N-terminal produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 384 amino acids （1-364 a.a.） ａnd having a molecular mass of 41.5 kDa. The ALDOA is purified by proprietary chromatographic techniques. |
| Source | Escherichia Coli. |
| Physical Appearance | Sterile Filtered clear colorless solution. |
| Formulation | The ALDOA solution contains 20mM Tris-HCl pH-8, 0.1M NaCl ａnd 20% glycerol. |
| Stability | ALDOA Recombinant Human although stable at 4°C for 30 days, should be stored desiccated below -20°C for periods greater than 30 days. Please avoid freeze-thaw cycles. |
| Amino acid sequence | MGSSHHHHHH SSGLVPRGSH MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASIC NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY. |
| Purity | Greater than 95.0% as determined by SDS-PAGE. |
| Usage | ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals. |
ALDOA,Human,重组人醛缩酶A
